Cholesterol 7α-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Impairs Very-Low-Density Lipoprotein Production

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 4, 2004, Pages 768-774

  Post, Sabine M ^a   Groenendijk, Martine ^a   Solaas, Karianne ^a   Rensen, Patrick C N ^a,b   Princen, Hans M G ^a  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bile acid biosynthesis; Cholesterol 7 hydroxylase; Mouse; SREBP 1; Triglycerides

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER; CYTOCHROME P450 ISOENZYME; MESSENGER RNA; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; VITAMIN; ACYLTRANSFERASE; ALPHA TOCOPHEROL; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E3 (LEIDEIN); DGAT1 PROTEIN, MOUSE; DIACYLGLYCEROL ACYLTRANSFERASE; KETONE BODY; RETINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BILE ACID SYNTHESIS; CATALYSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME DEFICIENCY; FECES LEVEL; FEMALE; GENE; GENE EXPRESSION; HYPERLIPIDEMIA; KNOCKOUT MOUSE; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN SYNTHESIS; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SREBF1 GENE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ATHEROGENIC DIET; BIOSYNTHESIS; BLOOD; CROSS BREEDING; FECES; GENETICS; HYPERLIPOPROTEINEMIA TYPE 3; LIPOLYSIS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ACYLTRANSFERASES; ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEINS B; APOLIPOPROTEINS E; BILE ACIDS AND SALTS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL ESTERS; CROSSES, GENETIC; DIACYLGLYCEROL O-ACYLTRANSFERASE; DIET, ATHEROGENIC; FECES; FEMALE; HYPERLIPOPROTEINEMIA TYPE III; KETONE BODIES; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEINS, VLDL; LIVER; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; STEROLS; TRIGLYCERIDES; VITAMIN A; VITAMIN E;

EID: 1842580406     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000121572.21122.59     Document Type: Article

References (34)

1. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry. 1992;31: 4737-4749.
2. Princen HMG, Post SM, Twisk J. Regulation of bile acid biosynthesis. Curr Pharmaceut Design. 1997;3:59-84.
3. Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev. 2002;23:443-463.
4. Carrella M, Ericsson S, Del Piano C, Angelin B, Einarsson K. Effect of cholestyramine treatment on biliary lipid secretion rates in normolipidaemic men. J Intern Med. 1991;229:241-246.
5. Lipid Research Clinics Program. JAMA. 1984;252:545-2548.
6. Miyake JH, Doung XD, Strauss W, Moore GL, Castellani LW, Curtiss LK, Taylor JM, Davis RA. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase. J Biol Chem. 2001;276:23304-23311.
7. Repa JJ, Lund EG, Horton JD, Leitersdorf E, Russell DW, Dietschy JM, Turley SD. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J Biol Chem. 2000;275:39685-39692.
8. Beil U, Crouse JR, Einarsson K, Grundy SM. Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides. Metabolism. 1982;31:438-444.
9. Angelin B, Einarsson K, Hellstrom K, Leijd B. Bile acid kinetics in relation to endogenous triglyceride metabolism in various types of hyperlipoproteinemia. J Lipid Res. 1978;19:1004-1016.
10. Einarsson K, Ericsson S, Ewerth S, Reihner E, Rudling M, Stahlberg D, Angelin B. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism. Eur J Clin Pharmacol. 1991;40:S53-S58.
11. Schwarz M, Lund EG, Setchell KD, Kayden HJ, Zerwekh JE, Bjorkhem I, Herz J, Russell DW. Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J Biol Chem. 1996;271:18024-18031.
12. van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, de Bruijn, I, van Vlijmen B, van Der Boom H, Havekes LM, Frants RR. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem. 1993;268:10540-10545.
13. Post SM, Zoeteweij JP, Bos MH, de Wit EC, Havinga R, Kuipers F, Princen HM. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat. Hepatology. 1999;30:491-500.
14. Zambon A, Hashimoto SI, Brunzell JD. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res. 1993;34: 1021-1028.
15. Post SM, de Crom R, van Haperen R, van Tol A, Princen HM. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein. Arterioscler Thromb Vasc Biol. 2003; 23:892-897.
16. Post SM, de Roos B, Vermeulen M, Afman L, Jong MC, Dahlmans VE, Havekes LM, Stellaard F, Katan MB, Princen HM. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis. Arterioscler Thromb Vasc Biol. 2000;20: 1551-1556.
17. Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood. 2003;101:545-551.
18. Erickson SK, Lear SR, Deane S, Dubrac S, Huling SL, Nguyen L, Bollineni JS, Shefer S, Hyogo H, Cohen DE, Shneider B, Sehayek E, Ananthanarayanan M, Balasubramaniyan N, Suchy FJ, Batta AK, Salen G. Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice. J Lipid Res. 2003;44:1001-1009.
19. van Vlijmen BJ, 't Hof HB, Mol MJ, van Der Boom H, van der ZA, Frants RR, Hofker MH, Havekes LM. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. J Clin Invest. 1996;97:1184-1192.
20. Einarsson K, Hellstrom K, Kallner M. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia. J Clin Invest. 1974;54:1301-1311.
21. Shelness GS, Sellers JA. Very-low-density lipoprotein assembly and secretion. Curr Opin Lipidol. 2001;12:151-157.
22. Raabe M, Flynn LM, Zlot CH, Wong JS, Veniant MM, Hamilton RL, Young SG. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci U S A. 1998;95:8686-8691.
23. Wang SL, Du EZ, Martin TD, Davis RA. Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1. J Biol Chem. 1997;272:19351-19358.
24. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem. 2002;277:9520-9528.
25. Suchy FJ, Sippel CJ, Ananthanarayanan M. Bile acid transport across the hepatocyte canalicular membrane. FASEB J. 1997;11:199-205.
26. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98:2088-2093.
27. Post SM, Duez H, Gervois PP, Staels B, Kuipers F, Princen HM. Fibrates Suppress Bile Acid Synthesis via Peroxisome Proliferator-Activated Receptor-alpha-Mediated Downregulation of Cholesterol 7alpha-Hydroxylase and Sterol 27-Hydroxylase Expression. Arterioscler Thromb Vasc Biol. 2001;21:1840-1845.
28. Sinal CJ, Yoon M, Gonzalez FJ. Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids. J Biol. Chem. 2001;276: 47154-47162.
29. Wiggins D, Gibbons GF. Origin of hepatic very-low-density lipoprotein triacylglycerol: the contribution of cellular phospholipid. Biochem J. 1996; 320:673-679.
30. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes: J Biol Chem. 1988;263:2998-3004.
31. Verkade HJ, Fast DG, Rusinol AE, Scraba DG, Vance DE. Impaired biosynthesis of phosphatidylcholine causes a decrease in the number of very low density lipoprotein particles in the Golgi but not in the endoplasmic reticulum of rat liver. J Biol Chem. 1993;268:24990-24996.
32. Vermeulen PS, Lingrell S, Yao Z, Vance DE. Phosphatidylcholine biosynthesis is required for secretion of truncated apolipoprotein Bs from McArdle RH7777 cells only when a neutral lipid core is formed. J Lipid Res. 1997; 38:447-458.
33. Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks JD, Williams KJ. The triple threat to nascent apolipoprotein B. Evidence for multiple distinct degradative pathways. J Biol Chem. 2001;276:278552-27863.
34. Pan M, Cederbaum AI, Williams KJ, Fisher EA. Reactive oxygen species regulate basal and induced degradation of apolipoprotein B in rat hepatic cells. Circulation. 2002;106(suppl II):II-2. Abstract.